Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.64 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.61 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.61 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.55 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.54 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.51 |
| ▸ | CYP21A2 | P08686 | 1/20 | 0.51 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.47 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29483362 | 1.00 | IDO1 (0.64) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL14489499 | 0.86 | IDO1 (0.75) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL28559272 | 0.80 | ENPP2 (0.64) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL870900 | 0.78 | IDO1 (0.64) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL22114976 | 0.78 | IDO1 (0.64) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL25138280 | 0.78 | IDO1 (0.64) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL3152446 | 0.78 | IDO1 (0.64) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL21020697 | 0.78 | IDO1 (0.64) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL5546083 | 0.78 | IDO1 (0.69) | IDO1ENPP2MKNK1MKNK2CYP3A4 | |
| SCHEMBL872242 | 0.78 | IDO1 (0.64) | IDO1ENPP2MKNK1MKNK2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119528905-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2025-02-28 | — | — | CN | claimed |
| CN-112592666-B | 360-DEG C-resistant high-temperature epoxy adhesive and preparation method and application thereof | 康达新材料(集团)股份有限公司 | 2022-11-25 | — | — | CN | claimed |
| CN-112592666-A | 360-DEG C-resistant high-temperature epoxy adhesive and preparation method and application thereof | 上海康达化工新材料集团股份有限公司 | 2021-04-02 | — | — | CN | claimed |
| EP-0557787-B1 | Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments | GRUENENTHAL GMBH (DE) | 2000-05-24 | — | — | EP | claimed |
| EP-0557787-A1 | Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments | Grünenthal GmbH (DE) | 1993-09-01 | — | — | EP | claimed |
| US-4500540-A | DIETETICS | HOFFMANN-LA ROCHE INC. (US) | 1985-02-19 | — | — | US | claimed |
| US-12522597-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2026-01-13 | — | — | US | disclosed |
| US-12509460-B2 | Methods and compositions for modulating splicing | SKYHAWK THERAPEUTICS, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-12319706-B2 | Organometallic compound, light-emitting device including the same, and electronic apparatus including the light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-06-03 | — | — | US | disclosed |
| CN-119528905-A | Methods and compositions for modulating splicing | 斯基霍克疗法公司 | 2025-02-28 | — | — | CN | disclosed |
| US-12144243-B2 | Organometallic compound, light-emitting device including same, and electronic apparatus including the light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-11-12 | — | — | US | disclosed |
| US-12035616-B2 | Organic electroluminescence device and organometallic complex for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
| US-12035616-B2 | Organic electroluminescence device and organometallic complex for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2024-07-09 | — | — | US | disclosed |
| EP-0557787-A1 | Imidazolylphenol derivatives, medicaments containing them and a process for the preparation of these compounds and medicaments | Grünenthal GmbH (DE) | 1993-09-01 | — | — | EP | disclosed |
| US-5194446-A | Antiarthritic agents | A. H. ROBINS COMPANY, INCORPORATED (US) | 1993-03-16 | — | — | US | disclosed |
| US-5192785-A | Sulfamates as antiglaucoma agents | A. H. ROBINS COMPANY, INCORPORATED (US) | 1993-03-09 | — | — | US | disclosed |
| EP-0496793-A1 | ENHANCED CHEMILUMINESCENT ASSAY. | BRITISH TECH GROUP (GB) | 1992-08-05 | — | — | EP | disclosed |
| US-5025031-A | Aryl and aryloxyalkyl sulfamate esters useful as anticonvulsants | A. H. ROBINS CO., INC. (US) | 1991-06-18 | — | — | US | disclosed |
| WO-1991005872-A1 | ENHANCED CHEMILUMINESCENT ASSAY | BRITISH TECHNOLOGY GROUP LTD (GB) | 1991-05-02 | — | — | WO | disclosed |
| EP-0403185-A2 | Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals | A.H. ROBINS COMPANY, INCORPORATED (US) | 1990-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509460-B2 | Methods and compositions for modulating splicing | SF3B1, RTCB, RBM17 | IDO1 4770/4885ENPP2 3113/4885MKNK1 2838/4885 |
| US-12035616-B2 | Organic electroluminescence device and organometallic complex for organic electroluminescence device | L1CAM, EML4, EPCAM | IDO1 2472/4885ENPP2 4464/4885MKNK1 3149/4885 |
| US-12144243-B2 | Organometallic compound, light-emitting device including same, and electronic apparatus including the light-emitting device | GPX1, LAGE3, NFE2L2 | IDO1 839/4885ENPP2 4447/4885MKNK1 3095/4885 |
| US-12319706-B2 | Organometallic compound, light-emitting device including the same, and electronic apparatus including the light-emitting device | CRY1, LAGE3, LEF1 | IDO1 1346/4885ENPP2 4286/4885MKNK1 3270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.